Today's drugs have somewhat solved a similar problem that the GLP1 presents, which is that it vanishes from the body quickly. But one of the ways they were able to delay it vanishing comes from scientists studying animal venoms. The first GLP1 receptor agonist was derived from heelomoster venom. Novo Nordisk and Eli Lilly solve the problem in different ways.

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode